Clinical trial
High-dose sequential chemotherapy and rituximab (R-HDS) in HIV+ patients with non-hodgkin lymphoma (NHL) refractory or relapsed after 1st line treatment
To assess incidence of infectious complications and mortality after R-HDS in HIV+ patients
| Category | Value |
|---|---|
| Study start date | 2007-12-10 |